Dose response study: small particle (Qvar + Ciclesonide) vs. large particle (FP + Clenil)

Lead Researcher:

 

Research Team:Status: Active

Support: Teva

Registration:

Short Description:

The aim of the study is to evaluate the relationship between ICS dose and treatment outcomes for patients prescribed small / large particle formulation by comparing asthma control outcomes and treatment-related side effects associated with different doses of each ICS in order to create real-life dose-response curves.

Protocol

Abstracts

Presentations

Final Publications

Additional Material